基本信息
浏览量:2
职业迁徙
个人简介
Dr. Jayson Parker is a Lecturer in medical biotechnology in the Department of Biology at the University of Toronto Mississauga. He lectures in the Master of Biotechnology Program, Faculty of Law and the Institute of Biomaterials and Biomedical Engineering. His main research interests include: biomarkers & clinical trial risk, machine learning, biotechnology patents and medical device regulation.
Dr. Parker is currently a medical/scientific advisor to the hedge fund Burlington Capital Inc, which has $25 million in assets under management and the Canadian Innovation Centre. He is also a board member for Life Sciences Ontario. Most recently, he was a medical liaison for Schering Plough’s biologic infliximab (Remicade) and for Novo Nordisk’s biologic rfVIIa (Novoseven/Niastase). He has been a “buy side” stock analyst covering the life sciences for Investor’s Group and the Director of Medical Science Equities at AIC limited (now Portland), both prominent mutual fund companies.
His research experience includes brain imaging of Alzheimer’s disease (Sunnybrook Hospital), animal models of alcohol abuse (Addiction Research Foundation) and animal models of schizophrenia (University of Toronto). His Doctoral work was on brain trauma (sensory map plasticity) and his Master’s research on cocaine addiction (reward pathways). During his MBA he focused on competitive intelligence issues in biotechnology.
Dr. Parker is currently a medical/scientific advisor to the hedge fund Burlington Capital Inc, which has $25 million in assets under management and the Canadian Innovation Centre. He is also a board member for Life Sciences Ontario. Most recently, he was a medical liaison for Schering Plough’s biologic infliximab (Remicade) and for Novo Nordisk’s biologic rfVIIa (Novoseven/Niastase). He has been a “buy side” stock analyst covering the life sciences for Investor’s Group and the Director of Medical Science Equities at AIC limited (now Portland), both prominent mutual fund companies.
His research experience includes brain imaging of Alzheimer’s disease (Sunnybrook Hospital), animal models of alcohol abuse (Addiction Research Foundation) and animal models of schizophrenia (University of Toronto). His Doctoral work was on brain trauma (sensory map plasticity) and his Master’s research on cocaine addiction (reward pathways). During his MBA he focused on competitive intelligence issues in biotechnology.
研究兴趣
论文共 27 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2020)
Companion and Complementary Diagnosticspp.399-412, (2019)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn